Approved Symbol |
Approved Name |
Source |
Evidence[PMID] |
ATM |
ataxia telangiectasia mutated |
Mapped by CNV; Mapped by significant region |
IDA[15790808]
|
SREBF1 |
sterol regulatory element binding transcription factor 1 |
Mapped by significant region |
|
POU2F3 |
POU class 2 homeobox 3 |
Mapped by significant region |
|
MYO7A |
myosin VIIA |
Mapped by significant region |
RCA[8622919]
|
SCAND3 |
SCAN domain containing 3 |
Mapped by LD-proxy |
|
TCF21 |
transcription factor 21 |
Mapped by CNV; Mapped by significant region |
|
TAL2 |
T-cell acute lymphocytic leukemia 2 |
Mapped by significant region |
|
WWOX |
WW domain containing oxidoreductase |
Mapped by significant region |
TAS[10786676]
|
TFAP2A |
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
Mapped by CNV |
IDA[12072434]
|
TBX1 |
T-box 1 |
Mapped by CNV |
TAS[17273972]
|
EBF1 |
early B-cell factor 1 |
Mapped by significant region |
|
ERBB2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
Mapped by LD-proxy |
NAS[12000754]
|
NPAS2 |
neuronal PAS domain protein 2 |
Mapped by CNV |
|
SLC4A11 |
solute carrier family 4, sodium borate transporter, member 11 |
Mapped by CNV |
|
HEY2 |
hairy/enhancer-of-split related with YRPW motif 2 |
Mapped by significant region |
|
PRDX5 |
peroxiredoxin 5 |
Mapped by significant region |
IDA[15046979]
|
OLIG3 |
oligodendrocyte transcription factor 3 |
Mapped by significant region |
|
GPR139 |
G protein-coupled receptor 139 |
Mapped by significant region |
|
NLGN1 |
neuroligin 1 |
Mapped by CNV |
|
PRKRIR |
protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) |
Mapped by significant region |
|
SPEF2 |
sperm flagellar 2 |
Mapped by significant region |
|